Myval THV matches SAPIEN and Evolut THVs in 30-day outcomes, supporting its role in severe aortic stenosis treatment.

Corporation (NASDAQ:NVNO), a medical device company with a market capitalization of $54.5 million, reported interim two-year follow-up data from its pivotal trial of the VenoValve, indicating ...

HSE advises that all hospitals using gas and air should carry out a COSHH risk assessment of each space in which it is used. Helen Jones, head of HSE’s health and public services sector said: “This is ...

Request To Download Free Sample of This Strategic Report @ Driving Forces of Growth: The unprecedented growth of the medical implant market is propelled by several key factors. Firstly, the aging ...

Middle-aged adults who need an aortic valve replacement fare better with mechanical devices than with the valves made from animal tissues that they currently most often receive, U.S. researchers ...

is a feasible and safe addition to preventing graft-versus-host disease in patients undergoing stem cell transplantation for blood cancers. ProCure On-Demand's 500th transplanted organ ...

"Lung transplantation is not always a durable solution because of the shortage of donors compared to the demand ... and after ...

As contemporary surgical practice continues to evolve, patients who undergo surgical lung volume reduction (LVRS) for ...

These findings may help to inform future treatment discussions and enhance aspects of physician-patient dialogue for patients on long-term prophylaxis and those using on-demand therapy only.

About 30 per cent of patients who require hospital admission ... we're really struggling with capacity to deal with this demand," president of the ACEM and director of Alice Springs emergency ...

LONDON - UK patients are “coming to harm” with hospitals so overwhelmed people are dying in corridors awaiting treatment amid a “collapse in care standards”, a report said on Jan 16.